KalVista Pharmaceuticals, Inc.
Developing oral protease inhibitors for rare diseases like hereditary angioedema (HAE).
KALV | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 200 CROSSING BOULEVARD, 1702 FRAMINGHAM
- Website:
- https://www.kalvista.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors. The company is dedicated to creating novel, orally-delivered therapies for rare diseases with significant unmet needs, with a primary focus on hereditary angioedema (HAE). Leveraging deep expertise in the kallikrein-kinin system, KalVista aims to transform the treatment landscape by developing innovative medicines, including an oral, on-demand treatment for HAE attacks, to empower patients to better manage their conditions and improve their quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all KalVista Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KalVista Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KalVista Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
